EP300 and leukemia: Similarly, peptidomimetics that achieved the inhibition of the assembly of the c-MYB-CBP/P300 complex also caused leukemia cell growth arrest and extended survival of immunodeficient mice engrafted with MLL-rearranged leukemia cells (Ramaswamy et al., 2018).